The taper connection between the sleeve and the base may not be able to accommodate the physiologic loads that occur during normal activity. If loads fracture the sleeve at the taper joint, it could lead to loss of function, loss of limb, infection, compromised soft tissue or death, according to the report.
A Class 1 recall is the FDA’s most serious warning. Hospitals and surgeons should immediately stop distributing or using the recalled lots. Currently DePuy is not recommending revision or follow-up for patients without symptoms.
More Articles on Devices:
MAKO Surgical Names Christopher Marrus Senior VP of Sales
FDA 510(k) Clearance Times Improved in 2011
Spine Surgery Coverage for New Technology Post Healthcare Reform: Q&A With Dr. Gunnar Andersson of Midwest Orthopaedics at Rush
FDA Issues Class 1 Recall for DePuy Revision Knee Device FeaturedWritten by Heather Linder | Monday, 25 February 2013 18:07
The FDA issued a Class 1 recall for DePuy Orthopaedics’ LPS Diaphyseal Sleeve, which is used with the LPS system as an end-stage revision knee device.
© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies here.
New from Becker's Orthopedic & Spine Review